glp 1 ocular side effects GLP-1 Receptor Agonists and the Eye GLP-1 drugs may be linked

Figure 21: Photograph of Professor Joel Habener, credit: Endocrine Society

Diabetes Res Clin Pract 150:167173 Ahern T et al (2013) Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study

The next-generation therapy combines semaglutide with cagrilintide, a long-acting analog of amylin, which is a pancreatic peptide that lowers blood glucose levels and slows down gastric emptying

Best outcomes happen when medication is paired with lifestyle changesnot used alone

A fish-like body odor can result from extreme excess consumption of TMA precursors such as choline, carnitine and betaine (usually unobtainable via regular dietary intake, it requires high levels of supplement intake)